false
0001603454
0001603454
2026-05-18
2026-05-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 18, 2026
Celcuity
Inc.
(Exact
name of Registrant as Specified in its Charter)
| Delaware |
|
001-38207 |
|
82-2863566 |
(State
or Other Jurisdiction
of
Incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
2800
Campus Drive, Suite 140
Minneapolis, Minnesota 55441
(Address
of Principal Executive Offices and Zip Code)
(763)
392-0123
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, $0.001 par value per share |
|
CELC |
|
The
Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item
5.02 |
Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On
May 14, 2026, Celcuity Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).
At the Annual Meeting, the Company’s stockholders (the “Stockholders”) approved the Company’s 2026 Stock Incentive
Plan (the “2026 Plan”).
The
Company’s Board of Directors (the “Board”) approved the 2026 Plan subject to Stockholder approval at the Annual Meeting.
The 2026 Plan became effective at the time of Stockholder approval. As a result of such approval, no further awards will be made under
the Company’s Amended and Restated 2017 Stock Incentive Plan (the “Prior Plan”). Subject to adjustment as provided
in the 2026 Plan, 3,000,000 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), may
be issued under the 2026 Plan. If outstanding awards issued under the 2026 Plan or the Prior Plan expire, are cancelled or forfeited,
or are settled or paid in cash before being exercised or settled in full, the shares subject to such awards will again be available for
issuance under the 2026 Plan.
Awards
under the 2026 Plan may be granted to employees, consultants, and non-employee directors of the Company and its subsidiaries in the form
of stock option awards, stock appreciation right awards, restricted stock awards, stock unit awards, and other stock-based awards. The
2026 Plan will be administered by the Compensation Committee of the Board.
At
the Annual Meeting, the Stockholders also approved the Company’s Amended and Restated 2017 Employee Stock Purchase Plan (the “Restated
ESPP”). The Restated ESPP increased the number of shares of Common Stock available for issuances under the 2017 Employee Stock
Purchase Plan (the “ESPP”) by 289,199 shares and extended the expiration date of the ESPP for an additional ten-year period.
The
Board approved the Restated ESPP subject to Stockholder approval at the Annual Meeting. The Restated ESPP became effective at the time
of Stockholder approval.
Copies
of the 2026 Plan and the Restated ESPP are attached to this Current Report on Form 8-K as Exhibits 10.1 and 10.2, respectively, and are
incorporated herein by reference. The material terms of the 2026 Plan and the Restated ESPP are set forth in the Company’s definitive
proxy statement relating to the Annual Meeting filed with the Securities and Exchange Commission on April 2, 2026.
| Item
5.07 |
Submission
of Matters to a Vote of Security Holders. |
At
the Annual Meeting:
| 1. | Stockholders
elected eight nominees to the Company’s Board of Directors to hold office until the
next annual meeting and the election of such director’s successor, or such director’s
earlier death, resignation or removal; |
| | | |
| 2. | Stockholders
ratified the appointment of Boulay PLLP as the Company’s independent registered public
accounting firm for the fiscal year ending December 31, 2026; |
| | | |
| 3. | Stockholders
approved, on an advisory basis, the compensation of the Company’s named executive officers; |
| | | |
| 4. | Stockholders
approved the 2026 Plan; and |
| | | |
| 5. | Stockholders
approved the Restated ESPP. |
The
voting results for each such matter were as follows:
| Nominee: |
|
For: |
|
Withheld: |
|
Broker
Non-Votes: |
| Richard
E. Buller |
|
34,066,928 |
|
3,639,283 |
|
3,622,556 |
| David
F. Dalvey |
|
31,918,122 |
|
5,788,089 |
|
3,622,556 |
| Leo
T. Furcht |
|
32,048,504 |
|
5,657,707 |
|
3,622,556 |
| Lance
G. Laing |
|
37,637,240 |
|
68,971 |
|
3,622,556 |
| Polly
A. Murphy |
|
34,360,198 |
|
3,346,013 |
|
3,622,556 |
| Richard
J. Nigon |
|
37,298,500 |
|
407,711 |
|
3,622,556 |
| Charles
R. Romp |
|
37,672,258 |
|
33,953 |
|
3,622,556 |
| Brian
F. Sullivan |
|
37,168,080 |
|
538,131 |
|
3,622,556 |
| 2. | Ratification
of the appointment of Boulay PLLP as the Company’s independent registered public accounting
firm for the fiscal year ending December 31, 2026: |
| For: |
|
Against: |
|
Abstain: |
|
Broker
Non-Votes: |
| 40,931,291 |
|
377,611 |
|
19,865 |
|
0 |
| 3. | Approval,
on an advisory basis, of the Company’s named executive officer compensation: |
| For: |
|
Against: |
|
Abstain: |
|
Broker
Non-Votes: |
| 35,835,588 |
|
1,846,980 |
|
23,643 |
|
3,622,556 |
| 4. | Approval
of the 2026 Plan: |
| For: |
|
Against: |
|
Abstain: |
|
Broker
Non-Votes: |
| 28,691,350 |
|
9,002,785 |
|
12,076 |
|
3,622,556 |
| 5. | Approval
of the Restated ESPP: |
| For: |
|
Against: |
|
Abstain: |
|
Broker
Non-Votes: |
| 35,067,849 |
|
2,623,058 |
|
15,304 |
|
3,622,556 |
| Item
9.01 |
Financial
Statements and Exhibits. |
| 10.1 |
|
Celcuity Inc. 2026 Stock Incentive Plan. |
| 10.2 |
|
Celcuity Inc. Amended and Restated 2017 Employee Stock Purchase Plan. |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
May 18, 2026
| |
CELCUITY
INC. |
| |
|
| |
By: |
/s/
Brian F. Sullivan |
| |
|
Brian
F. Sullivan |
| |
|
Chief
Executive Officer |